You searched for "THRIVE"
An update on laryngeal reinnervation
Laryngeal paralysis remains very difficult to treat, but reinnervation offers many attractions. Laryngeal paralysis presents a unique and varied problem that requires a patient centred approach and a range of treatment options depending on laryngeal and patient factors. There is...BACO 2015: Meet the Key Brits
The triennial BACO is always a feast of academic and social activity – and BACO 2015 promises to be as busy as ever. We hear from three of the key British speakers who are making big contributions to this year’s...First drop-in ENT digital nasendoscopy clinic – coming May 2026
The University Hospitals of North Midlands (UHNM) NHS Trust will open its first ‘drop-in’ digital nasendoscopy clinic in May 2026 at the newly established Clinical Diagnostic Centre (CDC) in Hanley, Stoke-on-Trent. The service aims to provide rapid reassurance for patients and help detect head and neck cancers early.William Hunter’s work on the anatomy of the human ear
The Hunterian Society offers an annual award for an essay and presentation on a subject of relevance to John or William Hunter, or medicine in the 18th Century. This article is based on Emma Stapleton’s 2014 winning essay, which was...In conversation with Professor Gao Zhiqiang
Prof Zhiqiang, President of the Chinese Society of Otorhinolaryngology, Head and Neck surgery takes us on a journey spanning over a hundred years of ENT in China: A story of an amazing achievement in a country with a population over...In Conversation with Professor John Russell, President of CEORL-HNS Dublin 2024
John Russell is professor of paediatric otolaryngology in Dublin and the President of the CEORL-HNS Congress in his hometown. Declan Costello caught up with him to find out what we can expect from the meeting, not just academically, but also...
Artificial intelligence and OSA
The future’s bright, the future’s Orange AI… If you Google ‘how much is AI worth?’, the AI overview tells you “The global artificial intelligence (AI) market size is estimated at approximately $244 billion to $391 billion in 2025 and is...
Bevacizumab, NF2, hearing and age
Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....
Incidental paranasal sinus fungal balls
Fungal ball (FB) sinusitis, also referred to as mycetoma or aspergilloma, is a chronic non-invasive mycotic disease. This study aimed at analysing the natural history and outcomes of patients with incidental paranasal FB on imaging. This was a retrospective study...
